Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immunocore Holdings (IMCR) Interest & Investment Income: 2021-2025

Historic Interest & Investment Income for Immunocore Holdings (IMCR) over the last 3 years, with Sep 2025 value amounting to $4.1 million.

  • Immunocore Holdings' Interest & Investment Income fell 30.82% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.7 million, marking a year-over-year decrease of 31.45%. This contributed to the annual value of $25.6 million for FY2024, which is 42.43% up from last year.
  • As of Q3 2025, Immunocore Holdings' Interest & Investment Income stood at $4.1 million, which was down 3.47% from $4.3 million recorded in Q2 2025.
  • In the past 5 years, Immunocore Holdings' Interest & Investment Income ranged from a high of $8.2 million in Q1 2024 and a low of $7,000 during Q4 2021.
  • Moreover, its 3-year median value for Interest & Investment Income was $5.1 million (2023), whereas its average is $5.1 million.
  • Per our database at Business Quant, Immunocore Holdings' Interest & Investment Income spiked by 163.62% in 2024 and then plummeted by 49.36% in 2025.
  • Immunocore Holdings' Interest & Investment Income (Quarterly) stood at $7,000 in 2021, then reached $5.4 million in 2023, then declined by 4.91% to $5.2 million in 2024, then slumped by 30.82% to $4.1 million in 2025.
  • Its last three reported values are $4.1 million in Q3 2025, $4.3 million for Q2 2025, and $4.2 million during Q1 2025.